Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Fascinating presentation by Prof. Sophie Susen at the LFB symposium during ISTH 2026, spotlighting the critical need for tailored dosing in von Willebrand disease (VWD)!
Perioperative VWD management is highly complex due to intricate VWF/FVIII dynamics and sheer clinical heterogeneity—truly a ‘kaleidoscope’ of rare subtypes.
Prof. Susen shared valuable insights on the first pharmacokinetic (PK) model developed specifically for pure VWF in this setting:
Bodyweight drives dosing needs: Underweight patients may need up to a 33% dose increase to hit target exposure, while patients with obesity may require a 50% dose reduction to prevent excessive VWF exposure.
Improved prediction accuracy: The novel population PK/PD model successfully integrates key covariates (VWD type, age, body weight, blood type, VWFpp) to predict VWF:Ag levels with high precision.
Fantastic to see decades of real-world evidence translating into actionable clinical tools.
Eagerly anticipating the prospective, multicenter WIL-PKPOP-CHIR validation study beginning enrollment later this year!”

Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden